Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Huajin Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical company specializing in the production of xanthine-based active pharmaceutical ingredients (APIs) and finished dosage forms. Established in 1987 and headquartered in Shijiazhuang, the company has become one of the world's largest manufacturers of Caffeine, Theophylline, and Aminophylline. Huajin operates state-of-the-art manufacturing facilities that are compliant with international GMP standards, holding certifications from the US FDA and European EDQM. Their products are exported to more than 70 countries, serving major global brands in the pharmaceutical and beverage sectors. The company focuses on large-scale chemical synthesis and maintains a robust quality management system to ensure its position as a key supplier in the global generic drug market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huajin Pharmaceutical.